Ativan and Injection site mass - a phase IV clinical study of FDA data

Summary:

Injection site mass is reported as a side effect among people who take Ativan (lorazepam), especially for people who are female, 60+ old, also take Synthroid, and have Carcinoid tumor.

The phase IV clinical study analyzes which people have Injection site mass when taking Ativan. It is created by eHealthMe based on reports of 74,376 people who have side effects when taking Ativan from the FDA, and is updated regularly.

What is Ativan?

Ativan has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 78,506 Ativan users. Check the latest studies of Ativan.

What is Injection site mass?

Injection site mass is found to be associated with 835 drugs and 786 conditions by eHealthMe. Check the latest studies of Injection site mass.

On Jul, 17, 2026

74,376 people reported to have side effects when taking Ativan.
Among them, 95 people (0.13%) have Injection site mass.

Among these 95 people:

What is the gender of people who have Injection site mass when taking Ativan? *

female: 83.7 %
male: 16.3 %

What is the age of people who have Injection site mass when taking Ativan? *

What are other drugs people take besides Ativan? *

What are other side effects people have besides Injection site mass? *

Injection Site Pain: 36 people, 37.89%
Injection Site Erythema (redness at injection site): 24 people, 25.26%
Rashes (redness): 23 people, 24.21%
Injection Site Bruising: 21 people, 22.11%
Diarrhea: 20 people, 21.05%
Fatigue (feeling of tiredness): 20 people, 21.05%
Weight Decreased: 18 people, 18.95%
Injection Site Pruritus (severe itching at injection site): 17 people, 17.89%
Nausea (feeling of having an urge to vomit): 17 people, 17.89%
Pain: 16 people, 16.84%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 12.63%
Carcinoid Tumor: 12 people, 12.63%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 9.47%
Pain: 8 people, 8.42%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 8 people, 8.42%
High Blood Pressure: 6 people, 6.32%
Depression: 6 people, 6.32%
Alcoholism (problems with alcohol): 5 people, 5.26%
Hypersensitivity: 5 people, 5.26%
Indigestion: 5 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ativan and have Injection site mass?

- Check whether Injection site mass is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ativan:

Ativan (78,506 reports)

Browse all side effects of Ativan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site mass:

Injection site mass (835 drugs)

Browse all the conditions that are associated with Injection site mass:

Injection site mass (786 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Ativan) and Ativan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.